Pharmacotherapy and mortality in atrial fibrillation—a cohort of men and women 75 years or older in Sweden.

Background: atrial fibrillation (AF) is a common cardiovascular morbidity, not least among elderly people, and is treated with different classes of cardiovascular pharmacotherapies.Hypothesis: cardiovascular drugs may have a different impact on survival in elderly patients with AF in primary health...

Descripción completa

Detalles Bibliográficos
Publicado en:	Age & Ageing Vol. 44; no. 2; pp. 232 - 239
Autores principales:	Wändell, Per Erik, Carlsson, Axel Carl, Sundquist, Jan, Johansson, Sven-Erik, Bottai, Matteo, Sundquist, Kristina
Formato:	Artículo
Publicado:	Oxford University Press / USA Mar2015
Materias:	Sweden Mortality Therapeutics Therapeutic use of fibrinolytic agents Cardiovascular agents Atrial fibrillation Chi-squared test Confidence intervals Fisher exact test Regression analysis Research funding Survival T-test (Statistics) Proportional hazards models Data analysis software Descriptive statistics Disease complications
Acceso en línea:	Ver este registro en EBSCOhost